Wednesday, July 8, 2026

pharma · Acne Rosacea · Atopic Dermatitis · DRMA

Dermata Therapeutics

Dermata Therapeutics is a pharma organization headquartered in San Diego, USA. It trades on NYSE under ticker DRMA. Primary therapeutic focus areas include Acne Rosacea, Atopic Dermatitis, Acne Vulgaris. NovaPharmaNews l

San Diego, USA HQ
2014 Founded
12 Employees
Public company Type
DRMA · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Founded
2014
Employees
12
Programs
4
Drugs
2
Patents
30
Clinical program

Topical Powder

Phase 2 · small molecule · Acne Rosacea

Topical Powder for Acne Rosacea is a Phase 2 program (small_molecule) at Dermata Therapeutics with 1 ClinicalTrials.gov record(s).

← All Dermata Therapeutics projects Phase 2 small molecule active

Internal code DMT310-005

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Dermata Therapeutics
Phase
Phase 2
Modality
small_molecule
Indication
Acne Rosacea
Status
active
Trials
1